首页> 外文OA文献 >Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

【2h】

Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

机译：生活质量分析来自于培美曲塞-卡铂-贝伐单抗，维持培美曲塞-贝伐单抗与紫杉醇-卡铂-贝伐单抗再继之维持贝伐单抗的培美曲塞-卡铂-贝伐单抗的随机，开放标签，III期PointBreak研究，分析IIIB或IV期非鳞状非-S期患者细胞肺癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Spigel David R.; Patel Jyoti D.; Reynolds Craig H.; Garon Edward B.; Hermann Robert C.; Govindan Ramaswamy; Olsen Mark R.; Winfree Katherine B.; Chen Jian; Liu Jingyi; Guba Susan C.; Socinski Mark A.; Bonomi Philip;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 20:50:10

相似文献

外文文献
中文文献
专利

1. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer [J] . Spigel David R., Patel Jyoti D., Reynolds Craig H., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第2期

机译：生活质量分析来自于培美曲塞-卡铂-贝伐单抗，维持培美曲塞-贝伐单抗与紫杉醇-卡铂-贝伐单抗再继之维持贝伐单抗的培美曲塞-卡铂-贝伐单抗的随机，开放标签，III期PointBreak研究，分析了IIIB或IV期非鳞状非-S患者细胞肺癌
2. Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non—Small-Cell Lung Cancer [J] . Craig H. Reynolds, Jyoti D. Patel, Edward B. Garon, Clinical lung cancer . 2015,第3期

机译：通过PointBreak研究对非洲裔美国人进行的探索性亚组分析：IIIB / IV期非鳞状非小细胞L型患者的培美曲塞-卡铂-贝伐单抗继之以维持治疗
3. Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer. [J] . Patel JD, Bonomi P, Socinski MA, Clinical lung cancer . 2009,第4期

机译：突破性研究的治疗原理和研究设计：培美曲塞/卡铂/贝伐单抗的随机，开放标签III期研究，然后进行培美曲塞/贝伐单抗与紫杉醇/卡铂/贝伐单抗的维持治疗，对IIIB或IV期非鳞状非IV期患者进行贝伐珠单抗治疗-小细胞肺癌。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer [O] . Jyoti D. Patel, Mark A. Socinski, Edward B. Garon, -1

机译：PointBreak：培美曲塞加卡铂和贝伐单抗继之维持治疗的随机III期研究ⅢB或IV期非鳞状非小细胞肺癌患者培美曲塞和贝伐单抗与紫杉醇加卡铂和贝伐珠单抗继之贝伐单抗维持治疗
7. PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer [O] . Zinner Ralph G., Obasaju Coleman K., Spigel David R., 2015

机译：方案：对于晚期非鳞状非小细胞肺癌患者，一线培美曲塞+卡铂联合维持培美曲塞与紫杉醇+卡铂+贝伐单抗联合贝伐珠单抗治疗的一线随机，开放标签，III期研究

著录项

相似文献

相关主题

期刊订阅